Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Middeldorp

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Infectious Agents and Cancer|October 14, 2010
Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30Colleen Pelser, Jaap Middeldorp, Sam M Mbulaiteye, et al.
Virology Journal|April 22, 2005
EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomasAbdelmajid Khabir, Hela Karray, Sandrine Rodriguez, et al.
Journal of Virology|October 18, 2005
In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatinCatherine Pioche-Durieu, Cécile Keryer, Sylvie Souquère, et al.
Virology|November 25, 2010
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivinJie Lu, Masanao Murakami, Subhash C Verma, et al.
Blood|February 15, 2003
Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trialGiuseppe Gerna, Daniele Lilleri, Fausto Baldanti, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasionMartin Rowe, Britt Glaunsinger, Daphne van Leeuwen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2005
Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcomeJoost J Oudejans, Ahemd Harijadi, Saskia A G M Cillessen, et al.
Journal of Medical Virology|January 3, 2013
Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinomaCindy Chang, Jaap Middeldorp, Kelly J Yu, et al.
Infectious Agents and Cancer|May 15, 2015
Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control studyDelphine Casabonne, Yolanda Benavente, Claudia Robles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in TaiwanAnna E Coghill, Ruth M Pfeiffer, Carla Proietti, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Infectious Agents and Cancer|October 14, 2010
Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30Colleen Pelser, Jaap Middeldorp, Sam M Mbulaiteye, et al.
Virology Journal|April 22, 2005
EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomasAbdelmajid Khabir, Hela Karray, Sandrine Rodriguez, et al.
Journal of Virology|October 18, 2005
In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatinCatherine Pioche-Durieu, Cécile Keryer, Sylvie Souquère, et al.
Virology|November 25, 2010
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivinJie Lu, Masanao Murakami, Subhash C Verma, et al.
Blood|February 15, 2003
Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trialGiuseppe Gerna, Daniele Lilleri, Fausto Baldanti, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasionMartin Rowe, Britt Glaunsinger, Daphne van Leeuwen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2005
Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcomeJoost J Oudejans, Ahemd Harijadi, Saskia A G M Cillessen, et al.
Journal of Medical Virology|January 3, 2013
Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinomaCindy Chang, Jaap Middeldorp, Kelly J Yu, et al.
Infectious Agents and Cancer|May 15, 2015
Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control studyDelphine Casabonne, Yolanda Benavente, Claudia Robles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in TaiwanAnna E Coghill, Ruth M Pfeiffer, Carla Proietti, et al.
Pageof 4